ResMed (RMD)
(Delayed Data from NYSE)
$203.15 USD
-0.73 (-0.36%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $203.00 -0.15 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum B VGM
Cash flow Statements
Fiscal Year End for ResMed Inc falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 897.56 | 779.44 | 474.51 | 621.67 |
Depreciation/Amortization & Depletion | NA | 197.56 | 193.84 | 191.52 | 181.37 |
Net Change from Assets/Liabilities | NA | -462.13 | -708.08 | 1.40 | -97.92 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 60.31 | 85.95 | 69.29 | 97.13 |
Net Cash From Operating Activities | NA | 693.30 | 351.15 | 736.72 | 802.26 |
Property & Equipment | NA | -119.67 | -134.84 | -102.71 | -95.33 |
Acquisition/ Disposition of Subsidiaries | NA | -1,012.75 | -42.78 | -39.07 | -27.91 |
Investments | NA | -28.29 | -13.92 | -21.79 | -31.62 |
Other Investing Activities | NA | 0.87 | -38.38 | 5.11 | -25.01 |
Net Cash from Investing Activities | NA | -1,159.85 | -229.92 | -158.46 | -179.86 |
Uses of Funds
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 49.14 | 47.38 | 37.79 | 48.18 |
Issuance (Repayment) of Debt | NA | 665.00 | 122.00 | -522.00 | -94.01 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | -258.28 | -245.34 | -226.71 | -225.09 |
Other Financing Activities | NA | -32.99 | -52.41 | -53.71 | -46.36 |
Net Cash from Financing Activities | NA | 422.87 | -128.36 | -764.63 | -317.29 |
Effect of Exchange Rate Changes | NA | -2.15 | -14.43 | 18.50 | 10.92 |
Net Change In Cash & Equivalents | NA | -45.82 | -21.57 | -167.88 | 316.03 |
Cash at Beginning of Period | NA | 273.71 | 295.28 | 463.16 | 147.13 |
Cash at End of Period | NA | 227.89 | 273.71 | 295.28 | 463.16 |
Diluted Net EPS | NA | 6.09 | 5.30 | 3.24 | 4.27 |
Fiscal Year End for ResMed Inc falls in the month of June.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 728.72 | 428.22 | 219.42 | 897.56 |
Depreciation/Amortization & Depletion | NA | 161.45 | 106.81 | 53.44 | 197.56 |
Net Change from Assets/Liabilities | NA | -12.34 | -53.15 | -9.59 | -462.13 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 83.32 | 77.24 | 23.01 | 60.31 |
Net Cash From Operating Activities | NA | 961.15 | 559.12 | 286.28 | 693.30 |
Property & Equipment | NA | -74.58 | -53.39 | -30.04 | -119.67 |
Acquisition/ Disposition of Subsidiaries | NA | -113.77 | -110.69 | -103.18 | -1,012.75 |
Investments | NA | -9.44 | -7.06 | -3.43 | -28.29 |
Other Investing Activities | NA | -25.49 | -18.99 | -12.33 | 0.87 |
Net Cash from Investing Activities | NA | -223.28 | -190.12 | -148.98 | -1,159.85 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | -74.61 | -29.50 | 0.98 | 49.14 |
Issuance (Repayment) of Debt | NA | -430.00 | -210.00 | -80.00 | 665.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | -211.77 | -141.28 | -70.60 | -258.28 |
Other Financing Activities | NA | -9.63 | -9.32 | -1.52 | -32.99 |
Net Cash from Financing Activities | NA | -726.00 | -390.09 | -151.13 | 422.87 |
Effect of Exchange Rate Changes | NA | -1.85 | 3.45 | -4.96 | -2.15 |
Net Change In Cash & Equivalents | NA | 10.02 | -17.64 | -18.79 | -45.82 |
Cash at Beginning of Period | NA | 227.89 | 227.89 | 227.89 | 273.71 |
Cash at End of Period | NA | 237.91 | 210.25 | 209.10 | 227.89 |
Diluted Net EPS | NA | 2.04 | 1.42 | 1.49 | 1.55 |